Catalyst Pharmaceutical Partners Inc buy StockNews.com
Start price
12.10.25
/
50%
€17.43
Target price
12.10.26
-
Performance (%)
14.12%
Price
15.12.25
€20.58
Summary
This prediction is currently active. The prediction currently has a performance of 14.12%. This prediction currently runs until 12.10.26. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Catalyst Pharmaceutical Partners Inc | 3.391% | 3.391% |
| iShares Core DAX® | 0.795% | 1.458% |
| iShares Nasdaq 100 | -3.088% | -0.762% |
| iShares Nikkei 225® | -0.952% | -2.268% |
| iShares S&P 500 | -1.393% | 0.199% |
Comments by StockNews_com for this prediction
In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Catalyst Pharmaceuticals (NASDAQ:CPRX) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Ratings data for CPRX provided by MarketBeat
Stopped prediction by StockNews_com for Catalyst Pharmaceutical Partners Inc
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€20.42
16.11.25
16.11.25
-
16.11.26
16.11.26
0.78%
15.12.25
15.12.25
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€16.81
21.09.25
21.09.25
-
21.09.26
21.09.26
22.46%
15.12.25
15.12.25
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€21.73
11.01.25
11.01.25
-
11.01.26
11.01.26
-5.29%
15.12.25
15.12.25
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€20.62
04.01.25
04.01.25
-
04.01.26
04.01.26
-0.19%
15.12.25
15.12.25
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€20.76
25.12.24
25.12.24
-
25.12.25
25.12.25
-0.87%
15.12.25
15.12.25
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€14.43
08.06.24
08.06.24
-
08.06.25
08.06.25
59.39%
09.06.25
09.06.25

